Erbb receptor signaling and therapeutic resistance to aromatase inhibitorsSHIN, Incheol; MILLER, Todd; ARTEAGA, Carlos L et al.Clinical cancer research. 2006, Vol 12, Num 3, issn 1078-0432, 1008s-1012s, 2Conference Paper

A fully human antitumor immunoRNase selective for ErbB-2-positive carcinomasDE LORENZO, Claudia; ARCIELLO, Angela; COZZOLINO, Rosanna et al.Cancer research (Baltimore). 2004, Vol 64, Num 14, pp 4870-4874, issn 0008-5472, 5 p.Article

Radiosensitization by pan ErbB inhibitor CI-1033 in vitro and in vivoNYATI, Mukesh K; MAHESHWARI, Divya; HANASOGE, Sheela et al.Clinical cancer research. 2004, Vol 10, Num 2, pp 691-700, issn 1078-0432, 10 p.Article

Expression of c-erbB-3 and c-erbB-4 proteins in papillary thyroid carcinomasFAKSVAG HAUGEN, D. R; AKSLEN, L. A; VARHAUG, J. E et al.Cancer research (Baltimore). 1996, Vol 56, Num 6, pp 1184-1188, issn 0008-5472Article

ERBB Receptor Activation Is Required for Profibrotic Responses to Transforming Growth Factor βANDRIANIFAHANANA, Mahefatiana; WILKES, Mark C; REPELLIN, Claire E et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 19, pp 7421-7430, issn 0008-5472, 10 p.Article

Rapid screening of cloned DNA fragments for specific mutationsTHEROUX, S. J; DAVIS, R. J.Nucleic acids research. 1992, Vol 20, Num 4, issn 0305-1048, p. 915Article

ErbB protein modifications are secondary to severe cell membrane alterations induced by elisidepsin treatmentVARADI, Timea; ROSZIK, Janos; LISBOA, Duarte et al.European journal of pharmacology. 2011, Vol 667, Num 1-3, pp 91-99, issn 0014-2999, 9 p.Article

Selective inhibition of ADAM metalloproteases as a novel approach for modulating ErbB pathways in cancerFRIDMAN, Jordan S; CAULDER, Eian; GRANDIS, Jennifer R et al.Clinical cancer research. 2007, Vol 13, Num 6, pp 1892-1902, issn 1078-0432, 11 p.Article

Analysis of ErbB Receptors in Pulmonary Carcinoid TumorsRICKMAN, Otis B; VOHRA, Pawan K; SANYAL, Bharati et al.Clinical cancer research (Print). 2009, Vol 15, Num 10, pp 3315-3324, issn 1078-0432, 10 p.Article

The performance of e23(Fv)PEs, recombinant toxins targeting the erbB-2 proteinKING, C. R; FISCHER, P. H; RANDO, R. F et al.Seminars in cancer biology. 1996, Vol 7, Num 2, pp 79-86, issn 1044-579XArticle

Contact spotting of protein microarrays coupled with spike-in of normalizer protein permits time-resolved analysis of ERBB receptor signalingLÖBKE, Christian; LAIBLE, Mark; RAPPL, Claudia et al.Proteomics (Weinheim. Print). 2008, Vol 8, Num 8, pp 1586-1594, issn 1615-9853, 9 p.Article

The erbB gene of avian erythroblastosis virus is A member of the src gene familyYAMAMOTO, T; NISHIDA, T; MIYAJIMA, N et al.Cell (Cambridge). 1983, Vol 35, Num 1, pp 71-78, issn 0092-8674Article

Metabolism and Disposition of [¹⁴C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to HumansCHRISTOPHER, Lisa J; HAIZHENG HONG; LYER, Ramaswamy A et al.Drug metabolism and disposition. 2010, Vol 38, Num 11, pp 2049-2059, issn 0090-9556, 11 p.Article

Site-specifically conjugated anti-HER2 Affibody® molecules as one-step reagents for target expression analyses on cells and xenograft samplesLUNDBERG, Emma; HÖIDEN-GUTHENBERG, Ingmarie; LARSSON, Barbro et al.Journal of immunological methods. 2007, Vol 319, Num 1-2, pp 53-63, issn 0022-1759, 11 p.Article

Amplification of the neu (c-erbB-2) oncogene in human mammary tumor is relatively frequent and its often accompanied by amplification of the linked c-erbA oncogeneVAN DE VIJVER, M; VAN DE BERSSELAAR, R; DEVILEE, P et al.Molecular and cellular biology (Print). 1987, Vol 7, Num 5, pp 2019-2023, issn 0270-7306Article

PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosineKAVANAUGH, W. M; TURCK, C. W; WILLIAMS, L. T et al.Science (Washington, D.C.). 1995, Vol 268, Num 5214, pp 1177-1179, issn 0036-8075Article

Protooncogene expression in normal and psoriatic skinELDER, J. T; TAVAKKOL, A; KLEIN, S. B et al.Journal of investigative dermatology. 1990, Vol 94, Num 1, pp 19-25, issn 0022-202X, 7 p.Article

Comparison of proto oncogene expression in seven primate fibroblast culturesNAKAMURA, K. D; HART, R. W.Mechanisms of ageing and development. 1987, Vol 39, Num 2, pp 177-187, issn 0047-6374Article

In Vitro Characterization of the Metabolic Pathways and Cytochrome P450 Inhibition and Induction Potential of BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor InhibitorHAIZHENG HONG; HONG SU; LI MA et al.Drug metabolism and disposition. 2011, Vol 39, Num 9, pp 1658-1667, issn 0090-9556, 10 p.Article

ErbB-2 gene expression in colorectal cancerTSIOULIAS, G. J; MUTO, T; MORIOKA, Y et al.Japanese journal of experimental medicine. 1990, Vol 60, Num 6, pp 343-349, issn 0021-5031Article

Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 networkLEBEDEVA, Galina; SOROKIN, Anatoly; FARATIAN, Dana et al.European journal of pharmaceutical sciences. 2012, Vol 46, Num 4, pp 244-258, issn 0928-0987, 15 p.Article

Translational research of a novel humanized epidermal growth factor receptor-related protein: a putative inhibitor of pan-ErbBFU, Xian-Hua; JUN LI; HUANG, Jian-Jin et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 6, pp 1373-1376, issn 0344-5704, 4 p.Article

ErbB Receptors: Directing key signaling networks throughout lifeHOLBRO, Thomas; HYNES, Nancy E.Annual review of pharmacology and toxicology. 2004, Vol 44, pp 195-217, issn 0362-1642, 23 p.Article

Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cellsKIM, Sung-Woo; CHAO, Ta-Hsiang; RONG XIANG et al.Cancer research (Baltimore). 2004, Vol 64, Num 21, pp 7732-7739, issn 0008-5472, 8 p.Article

Anticancer therapy targeting the erbB family of receptor tyrosine kinasesSLICHENMYER, William J; FRY, David W.Seminars in oncology. 2001, Vol 28, Num 5, pp 67-79, issn 0093-7754, SUP16Conference Paper